Table:
begin	end	state
1	5	non-cytoplasmic
6	25	transmembrane
26	31	cytoplasmic
32	52	transmembrane
53	63	non-cytoplasmic
64	83	transmembrane
84	103	cytoplasmic
104	133	transmembrane
134	138	non-cytoplasmic
139	161	transmembrane
162	180	cytoplasmic
181	201	transmembrane
202	230	non-cytoplasmic
231	254	transmembrane
255	264	cytoplasmic
265	287	transmembrane
288	308	non-cytoplasmic
309	322	transmembrane
323	346	non-cytoplasmic
347	382	transmembrane
383	388	cytoplasmic
389	412	transmembrane
413	423	non-cytoplasmic
424	446	transmembrane
447	449	cytoplasmic

Input:
>AO356_07790 AO356_07790 permease DsdX
MAPAFGYWLLVYAAIAIIALIVLIARYRLNPFIVITLVSIGLALLAGMPPSSVVGAYEAG
VGKTLGHIALVVALGTMLGKMMAESGGAERMAQTLIERFGERNAHWAMVCIAFLVGLPLF
FEVGFVLLVPIAFTIARRVGVSILMVGLPMVAGLSVVHALVPPHPAAMLAVQAFQASVGQ
TLLYAILIGIPTAIIAGPLYAKFIVPRIQLPAENPLERQFLDREPRARLPGFGVTLGTIL
LPVILMLIGGWANLISTPGSGFNQFLLFIGNSVIALLLATVLSFWTLGLAQGFNRESILK
FTNECLAPTASITLLVGAGGGLNRILVDAGVTQQIVGLAQEFQLSPLVMGWLFAALMRVA
TGSATVAMTTASGIVAPVAIGLGYPHPELLVLATGAGSVIFSHVNDGGFWLIKEYFNMTV
TQTFKTWTVLETLISVVAFALTLGLSRLL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server